Literature DB >> 24601987

Stable activity of diabetogenic cells with age in NOD mice: dynamics of reconstitution and adoptive diabetes transfer in immunocompromised mice.

Ayelet Kaminitz1, Keren Mizrahi, Shifra Ash, Avi Ben-Nun, Nadir Askenasy.   

Abstract

The non-obese diabetic (NOD) mouse is a prevalent disease model of type 1 diabetes. Immune aberrations that cause and propagate autoimmune insulitis in these mice are being continually debated, with evidence supporting both dominance of effector cells and insufficiency of suppressor mechanisms. In this study we assessed the behaviour of NOD lymphocytes under extreme expansion conditions using adoptive transfer into immunocompromised NOD.SCID (severe combined immunodeficiency) mice. CD4(+)  CD25(+) T cells do not cause islet inflammation, whereas splenocytes and CD4(+)  CD25(-) T cells induce pancreatic inflammation and hyperglycaemia in 80-100% of the NOD.SCID recipients. Adoptively transferred effector T cells migrate to the lymphoid organs and pancreas, proliferate, are activated in the target organ in situ and initiate inflammatory insulitis. Reconstitution of all components of the CD4(+) subset emphasizes the plastic capacity of different cell types to adopt effector and suppressor phenotypes. Furthermore, similar immune profiles of diabetic and euglycaemic NOD.SCID recipients demonstrate dissociation between fractional expression of CD25 and FoxP3 and the severity of insulitis. There were no evident and consistent differences in diabetogenic activity and immune reconstituting activity of T cells from pre-diabetic (11 weeks) and new onset diabetic NOD females. Similarities in immune phenotypes and variable distribution of effector and suppressor subsets in various stages of inflammation commend caution in interpretation of quantitative and qualitative aberrations as markers of disease severity in adoptive transfer experiments.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  adoptive transfer; diabetes; effector cells; immunophenotype; non-obese diabetic mice; regulatory cells

Mesh:

Year:  2014        PMID: 24601987      PMCID: PMC4080962          DOI: 10.1111/imm.12277

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  64 in total

Review 1.  Beta cell death and protection.

Authors:  Thomas Mandrup-Poulsen
Journal:  Ann N Y Acad Sci       Date:  2003-11       Impact factor: 5.691

2.  Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.

Authors:  Wen Yang; Shabbir Hussain; Qing-Sheng Mi; Pere Santamaria; Terry L Delovitch
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

3.  CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion.

Authors:  Maria A Curotto de Lafaille; Andreia C Lino; Nino Kutchukhidze; Juan J Lafaille
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

Review 4.  The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD.

Authors:  T L Delovitch; B Singh
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

5.  A sudden decline in active membrane-bound TGF-beta impairs both T regulatory cell function and protection against autoimmune diabetes.

Authors:  Randal K Gregg; Renu Jain; Scott J Schoenleber; Rohit Divekar; J Jeremiah Bell; Hyun-Hee Lee; Ping Yu; Habib Zaghouani
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

6.  Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice.

Authors:  L S Wicker; B J Miller; Y Mullen
Journal:  Diabetes       Date:  1986-08       Impact factor: 9.461

7.  Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice.

Authors:  H Yagi; M Matsumoto; K Kunimoto; J Kawaguchi; S Makino; M Harada
Journal:  Eur J Immunol       Date:  1992-09       Impact factor: 5.532

8.  Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus.

Authors:  Shuang Liang; Pascale Alard; Yuan Zhao; Sarah Parnell; Sherry L Clark; Michele M Kosiewicz
Journal:  J Exp Med       Date:  2005-01-03       Impact factor: 14.307

9.  Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes.

Authors:  P Höglund; J Mintern; C Waltzinger; W Heath; C Benoist; D Mathis
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

10.  T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice.

Authors:  C Boitard; R Yasunami; M Dardenne; J F Bach
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Mechanisms of diabetic autoimmunity: II--Is diabetes a central or peripheral disorder of effector and regulatory cells?

Authors:  Nadir Askenasy
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

Review 2.  Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.

Authors:  Nadir Askenasy
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

Review 3.  Mechanisms of diabetic autoimmunity: I--the inductive interface between islets and the immune system at onset of inflammation.

Authors:  Nadir Askenasy
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

4.  RNase L contributes to experimentally induced type 1 diabetes onset in mice.

Authors:  Chun Zeng; Xin Yi; Danny Zipris; Hongli Liu; Lin Zhang; Qiaoyun Zheng; Krishnamurthy Malathi; Ge Jin; Aimin Zhou
Journal:  J Endocrinol       Date:  2014-10-06       Impact factor: 4.286

5.  The influence of exendin-4 intervention on -obese diabetic mouse blood and the pancreatic tissue immune microenvironment.

Authors:  Jinshui He; Chaowei Lian; Yanling Fang; Jinzhi Wu; Huowang Zhou; Xiaoling Ye
Journal:  Exp Ther Med       Date:  2016-09-12       Impact factor: 2.447

6.  Fatty acid binding protein 4 promotes autoimmune diabetes by recruitment and activation of pancreatic islet macrophages.

Authors:  Yang Xiao; Lingling Shu; Xiaoping Wu; Yang Liu; Lai Yee Cheong; Boya Liao; Xiaoyu Xiao; Ruby Lc Hoo; Zhiguang Zhou; Aimin Xu
Journal:  JCI Insight       Date:  2021-04-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.